The State of Applying Artificial Intelligence to Tissue Imaging for Cancer Research and Early Detection

Artificial intelligence represents a new frontier in human medicine that could save more lives and reduce the costs, thereby increasing accessibility. As a consequence, the rate of advancement of AI in cancer medical imaging and more particularly tissue pathology has exploded, opening it to ethical and technical questions that could impede its adoption into existing systems. In order to chart the path of AI in its application to cancer tissue imaging, we review current work and identify how it can improve cancer pathology diagnostics and research. In this review, we identify 5 core tasks that models are developed for, including regression, classification, segmentation, generation, and compression tasks. We address the benefits and challenges that such methods face, and how they can be adapted for use in cancer prevention and treatment. The studies looked at in this paper represent the beginning of this field and future experiments will build on the foundations that we highlight

Machine Learning for Prostate Histopathology Assessment

Pathology reporting on radical prostatectomy (RP) specimens is essential to post-surgery patient care. However, current pathology interpretation of RP sections is typically qualitative and subject to intra- and inter-observer variability, which challenges quantitative and repeatable reporting of lesion grade, size, location, and spread. Therefore, we developed and validated a software platform that can automatically detect and grade cancerous regions on whole slide images (WSIs) of whole-mount RP sections to support quantitative and visual reporting. Our study used hæmatoxylin- and eosin-stained WSIs from 299 whole-mount RP sections from 71 patients, comprising 1.2 million 480μm×480μm regions-of-interest (ROIs) covering benign and cancerous tissues which contain all clinically relevant grade groups. Each cancerous region was annotated and graded by an expert genitourinary pathologist. We used a machine learning approach with 7 different classifiers (3 non-deep learning and 4 deep learning) to classify: 1) each ROI as cancerous vs. non-cancerous, and 2) each cancerous ROI as high- vs. low-grade. Since recent studies found some subtypes beyond Gleason grade to have independent prognostic value, we also used one deep learning method to classify each cancerous ROI from 87 RP sections of 25 patients as each of eight subtypes to support further clinical pathology research on this topic. We cross-validated each system against the expert annotations. To compensate for the staining variability across different WSIs from different patients, we computed the tissue component map (TCM) using our proposed adaptive thresholding algorithm to label nucleus pixels, global thresholding to label lumen pixels, and assigning the rest as stroma/other. Fine-tuning AlexNet with ROIs of the TCM yielded the best results for prostate cancer (PCa) detection and grading, with areas under the receiver operating characteristic curve (AUCs) of 0.98 and 0.93, respectively, followed by fine-tuned AlexNet with ROIs of the raw image. For subtype grading, fine-tuning AlexNet with ROIs of the raw image yielded AUCs ≥ 0.7 for seven of eight subtypes. To conclude, deep learning approaches outperformed non-deep learning approaches for PCa detection and grading. The TCMs provided the primary cues for PCa detection and grading. Machine learning can be used for subtype grading beyond the Gleason grading system

Deep Learning for Classification of Brain Tumor Histopathological Images

Histopathological image classification has been at the forefront of medical research. We evaluated several deep and non-deep learning models for brain tumor histopathological image classification. The challenges were characterized by an insufficient amount of training data and identical glioma features. We employed transfer learning to tackle these challenges. We also employed some state-of-the-art non-deep learning classifiers on histogram of gradient features extracted from our images, as well as features extracted using CNN activations. Data augmentation was utilized in our study. We obtained an 82% accuracy with DenseNet-201 as our best for the deep learning models and an 83.8% accuracy with ANN for the non-deep learning classifiers. The average of the diagonals of the confusion matrices for each model was calculated as their accuracy. The performance metrics criteria in this study are our model’s precision in classifying each class and their average classification accuracy. Our result emphasizes the significance of deep learning as an invaluable tool for histopathological image studies

Cluster Analysis of Cell Nuclei in H&E-Stained Histological Sections of Prostate Cancer and Classification Based on Traditional and Modern Artificial Intelligence Techniques

Biomarker identification is very important to differentiate the grade groups in the histopathological sections of prostate cancer (PCa). Assessing the cluster of cell nuclei is essential for pathological investigation. In this study, we present a computer-based method for cluster analyses of cell nuclei and performed traditional (i.e., unsupervised method) and modern (i.e., supervised method) artificial intelligence (AI) techniques for distinguishing the grade groups of PCa. Two datasets on PCa were collected to carry out this research. Histopathology samples were obtained from whole slides stained with hematoxylin and eosin (H&E). In this research, state-of-the-art approaches were proposed for color normalization, cell nuclei segmentation, feature selection, and classification. A traditional minimum spanning tree (MST) algorithm was employed to identify the clusters and better capture the proliferation and community structure of cell nuclei. K-medoids clustering and stacked ensemble machine learning (ML) approaches were used to perform traditional and modern AI-based classification. The binary and multiclass classification was derived to compare the model quality and results between the grades of PCa. Furthermore, a comparative analysis was carried out between traditional and modern AI techniques using different performance metrics (i.e., statistical parameters). Cluster features of the cell nuclei can be useful information for cancer grading. However, further validation of cluster analysis is required to accomplish astounding classification results.ope

Minimally Invasive Urological Procedures and Related Technological Developments

The landscape of minimally invasive urological intervention is changing. A lot of new innovations and technological developments have happened over the last 3 decades. Laparoscopy and robotic surgery have revolutionised kidney and prostate cancer treatment, with more minimally invasive procedures now being carried out than ever before. At the same time, technological advancements and the use of laser have changed the face of endourology. Several new innovative treatments are now commonplace for benign prostate enlargement (BPE). Management of prostate cancer now involves procedures such as robotic prostatectomy, brachytherapy, radiotherapy, cryotherapy and HIFU. Robotic partial nephrectomy and cryotherapy have changed the face of renal cancer. En-bloc resection of bladder cancer is challenging the traditional management of non-muscle invasive bladder cancer and becoming commonplace, while robotic cystectomy is also gaining popularity for muscle invasive bladder cancer. Newer surgical intervention related to BPE includes laser (holmium, thulium and green light), water-based treatment (Rezum, Aquablation) and other minimally invasive procedures such as prostate artery embolisation (PAE) and Urolift. Endourological procedures have incorporated newer laser types and settings such as moses technology, disposable ureteroscopes (URS) and minimisation of percutaneous nephrolithotomy (PCNL) instruments. All these technological innovations and improvements have led to shorter hospital stay, reduced cost, potential reduction in complications and improvement in the quality of life (QoL)